Marie-Louise Fjaellskog

Marie-Louise Fjaellskog

Director/Board Member at FARON PHARMACEUTICALS OY

59 year
Health Technology
Consumer Services

Profile

Marie-Louise Fjaellskog is currently a Non-Executive Director at Faron Pharmaceuticals Oy and a Director at Lytix Biopharma AS.
She also holds the position of Director at Biovica International AB since 2020 and has been an Associate Professor at the University of Uppsala since 2008.
Previously, she served as Vice President-Clinical Development at Infinity Pharmaceuticals, Inc. from 2018 to 2019 and at Merus NV from 2019 to 2020.
She also worked as the Chief Medical Officer at Sensei Biotherapeutics, Inc. Dr. Fjaellskog holds a doctorate degree from the University of Uppsala.

Marie-Louise Fjaellskog active positions

CompaniesPositionStart
FARON PHARMACEUTICALS OY Director/Board Member 2023-09-21
BIOVICA INTERNATIONAL AB Director/Board Member 2019-12-31
LYTIX BIOPHARMA Director/Board Member -
University of Uppsala Corporate Officer/Principal 2008-11-30
All active positions of Marie-Louise Fjaellskog

Former positions of Marie-Louise Fjaellskog

CompaniesPositionEnd
MERUS N.V. Chief Tech/Sci/R&D Officer 2020-05-31
INFINITY PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2019-03-31
SENSEI BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Marie-Louise Fjaellskog's experience

Training of Marie-Louise Fjaellskog

University of Uppsala Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marie-Louise Fjaellskog's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
INFINITY PHARMACEUTICALS, INC.

Health Technology

FARON PHARMACEUTICALS OY

Health Technology

MERUS N.V.

Health Technology

LYTIX BIOPHARMA

Health Technology

BIOVICA INTERNATIONAL AB

Health Technology

SENSEI BIOTHERAPEUTICS, INC.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Marie-Louise Fjaellskog